Avalon Pharmaceuticals to Present at 2005 BIO InvestorForum
October 14 2005 - 12:45PM
PR Newswire (US)
GERMANTOWN, Md., Oct. 14 /PRNewswire-FirstCall/ -- Avalon
Pharmaceuticals, Inc. (Nasdaq and ArcaEx(R): AVRX) today announced
that Kenneth C. Carter, Ph.D., President and CEO is scheduled to
present at the BIO InvestorForum at The Palace Hotel in San
Francisco on Wednesday, October 19th. The presentation will begin
at 2:00 pm PDT (5:00 pm EDT) in the Presidio Room. The presentation
will be webcast live and can be accessed at
http://www.avalonrx.com/ under Investor Relations / Upcoming
Presentations. The webcast will also be archived for 90 days
following the presentation. About Avalon Pharmaceuticals Avalon
Pharmaceuticals is a biopharmaceutical company focused on the
discovery and development of small molecule therapeutics for the
treatment of cancer. Avalon seeks to discover and develop novel
therapeutics through the use of a comprehensive, innovative and
proprietary suite of technologies based upon large-scale gene
expression analysis which it calls AvalonRx(R). Avalon
Pharmaceuticals was established in 1999 and is headquartered in
Germantown, Maryland. This announcement contains, in addition to
historical information, certain forward-looking statements that
involve risks and uncertainties, in particular, related to Avalon's
ability to close its initial public offering and, if its is able to
close the offering, the level of its share price, which may
decline, and other statements about its research and development
activities, including development of AVN944, its collaboration
agreements, and its ability to successfully complete preclinical
and clinical testing. Such statements reflect the current views of
Avalon management and are based on certain assumptions. Actual
results could differ materially from those currently anticipated as
a result of a number of factors, risks and uncertainties. All
forward looking statements are qualified in their entirety by this
cautionary statement and the company undertakes no obligation to
revise or update this news release to reflect events or
circumstances after the date hereof. Contacts: Avalon
Pharmaceuticals Gary Lessing Chief Financial Officer Tel: (301)
556-9828 Fax: (301) 556-9910 Email: Wendy Lau Noonan Russo Tel:
(212) 845-4272 Email: DATASOURCE: Avalon Pharmaceuticals, Inc.
CONTACT: Gary Lessing, Chief Financial Officer of Avalon
Pharmaceuticals, +1-301-556-9828, Fax: +1-301-556-9910, ; or Wendy
Lau of Noonan Russo, +1-212-845-4272, Web site:
http://www.avalonrx.com/
Copyright